Do Negative (124)I Pretherapy Positron Emission Tomography Scans in Patients with Elevated Serum Thyroglobulin Levels Predict Negative (131)I Posttherapy Scans?

Background: The management of patients with differentiated thyroid cancer (DTC) who have elevated serum thyroglobulin (Tg) levels and negative (131)I or (123)I scans is problematic, and the decision regarding whether or not to administer (131)I therapy (a “blind” therapy) is also problematic. While...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Khorjekar, Gauri R., Van Nostrand, Douglas, Garcia, Carlos, O'Neil, Jeffrey, Moreau, Shari, Atkins, Francis B., Mete, Mihriye, Orquiza, Michael H., Burman, Kenneth, Wartofsky, Leonard
Format: Artigo
Sprache:Inglês
Veröffentlicht: Mary Ann Liebert, Inc. 2014
Schlagworte:
Thyroid Radiology and Nuclear Medicine
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4148053/
https://ncbi.nlm.nih.gov/pubmed/24820222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/thy.2013.0713
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge